Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

醋酸奥曲肽注射液 - NMPA Drug Approval Details

Approvals/NMPA/Octreotide Acetate Injection

Approved

化学药品

Octreotide Acetate Injection

再维药业（海南）有限公司🇨🇳 National Medical Products Administration

Approval Date: Dec 30, 2022
Approval ID: 705ceaca93429686
Company: 再维药业（海南）有限公司
Type: 化学药品

Approval Details

Approval Id: 705ceaca93429686
Approval Number: 国药准字H20223960
Generic Name: 醋酸奥曲肽注射液
Generic Name En: Octreotide Acetate Injection
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 1ml:0.1mg（以C₄₉H₆₆N₁₀O₁₀S₂计）
Reg Date: 2022-12-30
Company Name: 再维药业（海南）有限公司
Company Address: 海南省澄迈县老城镇高新技术产业示范区海南生态软件园沃克公园C8855幢四层B区
Production Company Name: 哈尔滨三联药业股份有限公司
Production Company Address: 哈尔滨市利民开发区北京路
Company Detail Path: /organization/3d6f0d7084be7619/zai-wei-yao-ye-hai-nan-you-xian-gong-si
Production Company Detail Path: /organization/c68cf1797325d5d9/harbin-medisan-pharmaceutical-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 30, 2022

Approval ID

705ceaca93429686

Type

化学药品

Back to NMPA Approvals